Gotham Asset Management »

Gain Therapeutics shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.4M 335k 22.05

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Etf Tr Gotham Enhncd (GSPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Tidal Etf Tr Gotham 1000 Valu (GVLU)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)
Snowflake Cl A (SNOW)
Qualcomm (QCOM)
Ishares Core Msci Emkt (IEMG)
Nrg Energy Com New (NRG)

View all positions for Gotham Asset Management

Top funds holding Gain Therapeutics

DME Capital Management
Gotham Asset Management
Geode Capital Management
Vanguard Group
Cable Car Capital
BlackRock
BlackRock
Jones Financial Companies, L.L
Renaissance Technologies
Northern Trust
Bridgeway Capital Management
State Street Corporation
Susquehanna International
Simplex Trading
Creekmur Asset Management

View all funds holding Gain Therapeutics